Linda Elisabet Campbell

Linda Elisabet Campbell

Auto-generated profile, based on publicly available information

Linda Elisabet Campbell

University of Newcastle

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in American Journal of Psychiatry
Verified
Journal Article
Closed access
MSMaude Schneider
Maude Schneider
Martin DebbanéMartin Debbané
Martin Debbané
ABAnne S. Bassett
Anne S. Bassett
ECEva W.C. Chow
Eva W.C. Chow
WFWai Lun Alan Fung
Wai Lun Alan Fung
BSBehavior In 22Q11.2 Deletion Syndrome
Behavior In 22Q11.2 Deletion Syndrome

14 April 2004 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
PHPeter Hammond
Peter Hammond
THTim J. Hutton
Tim J. Hutton
JAJudith E. Allanson
Judith E. Allanson
LCLinda E. Campbell
Linda E. Campbell
RHRaoul C.M. Hennekam
Raoul C.M. Hennekam
RWRobin M. Winter
Robin M. Winter

28 March 2006 in Brain
Verified
Journal Article
Open access
PDF file
LCLinda E. Campbell
Linda E. Campbell
EDEileen Daly
Eileen Daly
FTFiona Toal
Fiona Toal
ASAngela Stevens
Angela Stevens
RARayna Azuma
Rayna Azuma
KMKieran C. Murphy
Kieran C. Murphy
In people with velo-cardio-facial syndrome [or 22q11.2 deletion syndrome (22qDS)], a single interstitial deletion of chromosome 22q11.2 causes a wide spectrum of cognitive deficits ranging from global learning difficulties to specific cognitive deficits. People with 22qDS are also at high risk of developing attention-deficit/hyperactivity disorder and autism spectrum disorders in childhood, and schizophrenia in adolescence or adult life. However, the neurobiology of 22qDS, and the relationship between abnormalities in brain anatomy and behaviour, is poorly understood. Thus, we studied the neuroanatomy of 22qDS children using fully automated voxel-based morphometry (VBM) and manually traced single region-of-interest (ROI) analysis. Also, we investigated whether those brain regions that differed significantly between groups were related to behavioural differences within children with 22qDS. We compared the brain morphometry of 39 children and adolescents with 22qDS (mean age: 11 years, SD ±3, IQ = 67, SD ±10) and 26 sibling controls (mean age: 11 years, SD ±3, IQ = 102, SD ±12). Using VBM, we found, after correction for IQ, that individuals with 22qDS compared with controls had a significant reduction in cerebellar grey matter, and white matter reductions in the frontal lobe, cerebellum and internal capsule. Using single ROI analysis, we found that people with 22qDS had a significant (P < 0.05) reduction in bulk volume bilaterally in the occipital-parietal lobes, but a larger right caudate nucleus and lateral ventricles. Further, within people with 22qDS, there was a significant positive correlation between severity of (i) schizotypy score and grey matter volume of the temporo-occipital regions and the corpus striatum; (ii) emotional problems and grey matter volume of frontostriatal regions; and (iii) social behavioural difficulties and grey matter in frontostriatal regions. Thus, subjects with 22qDS have widespread changes in brain anatomy, particularly affecting white matter, basal ganglia and cerebellum. Also, within 22qDS, regionally specific differences in brain development may partially underpin behavioural differences. We suggest that there is preliminary evidence for specific vulnerability of the frontostriatal and cerebellar-cortical networks in 22qDS.

29 May 2012 in Australian & New Zealand Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
HSHelen J Stain
Helen J Stain
CGCherrie A Galletly
Cherrie A Galletly
SCScott Clark
Scott Clark
JWJacqueline Wilson
Jacqueline Wilson
EKEmily A Killen
Emily A Killen
CHCarol Harvey
Carol Harvey
Background: Social inclusion is a key priority of the Fourth National Mental Health Plan for Australia (2009–2014), with strong evidence for its protective impact on mental health. Social integration has been associated with enhanced well-being for people with mental illnesses such as psychosis. Objective: To explore the impact of psychosis on an individual’s social and community participation. Method: The second Australian national survey of psychosis was conducted across seven Australian sites. Semi-structured interviews with adults living with psychosis assessed mental health status, social and role functioning, life satisfaction and future goals. The cohort comprised 1825 adults with a psychotic illness (59.6% were male; 42.4% were aged 18–34 years; 31.5% had 12 years or more of education) of whom 32.7% had been employed in the past year. Results: Most adults indicated experiencing loneliness (80.1%) and a need for more friends (48.1%). Men were more likely to have never had a long-term relationship (59.4% M, 33.2% F). Even though women were more likely to experience anxiety in social situations [(χ 2 (1) = 8.95, p < 0.01)], they were more likely to have attended a social activity in the past year [χ 2 (2) = 11.84, p < 0.01]. Just over half of the survey participants (56.7%) reported having daily or nearly daily contact with family members. In the past year, 69% had not attended any social activity and 43% described stigma as a barrier. Although 63.2% showed significant impairment in social functioning, only 29.5% had received help for this in the last year. Social isolation and loneliness were rated as major challenges by 37.2% of the cohort. Conclusions: Social isolation and dysfunction experienced by people with psychosis have not decreased since the last Australian national survey of people with psychosis. Alongside education and employment, social functioning and participation must be addressed to improve social inclusion for people with psychosis. Programs targeting social opportunities (befriending, peer support), social anxiety and social functioning for all stages of psychosis are warranted.

1 December 2005 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
PHPeter Hammond
Peter Hammond
THTim J. Hutton
Tim J. Hutton
JAJudith E. Allanson
Judith E. Allanson
BBBernard Buxton
Bernard Buxton
LCLinda E. Campbell
Linda E. Campbell
MTMay Tassabehji
May Tassabehji

9 November 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
RDRobert W. Davies
Robert W. Davies
AFAnia M. Fiksinski
Ania M. Fiksinski
EBElemi J. Breetvelt
Elemi J. Breetvelt
NWNigel M. Williams
Nigel M. Williams
SHStephen R. Hooper
Stephen R. Hooper
JVJacob Vorstman
Jacob Vorstman